Browse > Article
http://dx.doi.org/10.14776/piv.2020.27.e15

Group A Streptococcal Bacteremia in Pediatric Patients: A Single-Center Study  

Kim, Dongsub (Department of Pediatrics, Kyungpook National University Hospital, School of Medicine, Kyungpook National University)
Publication Information
Pediatric Infection and Vaccine / v.27, no.2, 2020 , pp. 83-89 More about this Journal
Abstract
Purpose: Group A streptococcus (GAS) is a common pathogen in pediatric patients and often causes acute pharyngotonsillitis and skin and soft tissue infections. In addition, bacteremia with significant morbidity and mortality can also occur. This study was conducted to describe the clinical manifestations and treatment outcomes of pediatric GAS bacteremia patients in Korea. Methods: This was a single-center, retrospective study. From January 2000 to December 2016, pediatric patients aged ≤18 years with GAS bacteremia were studied. Clinical manifestations, underlying diseases, intensive care unit stay, and antibiotic susceptibility were evaluated. Results: During the study period, 19 patients had GAS bacteremia. Ten (53%) were male, and the median age was 7.4 years (range, 0.3-17.4 years). Fourteen (74%) had chronic underlying diseases. Five (26%) were immunocompromised (leukemia and chronic kidney disease). Eight (42%) had lymphatic or vascular malformations, of which seven had lesions with signs of inflammation. Three (16%) developed pneumonia, and two of them received ventilator care. The 30-day mortality rate was 6% (1/19), and the cause of death was bacteremic pneumonia. All GAS isolates were sensitive to penicillin. Fifteen (79%) were sensitive to both erythromycin and clindamycin. Conclusions: This study identified various clinical manifestations of GAS bacteremia. GAS should be considered as a potential pathogen that can cause bacteremia and result in a serious clinical course.
Keywords
Streptococcus pyogenes; Bacteremia;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Laupland KB, Davies HD, Low DE, Schwartz B, Green K, McGeer A, et al. Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Pediatrics 2000;105:e60.   DOI
2 Okamoto S, Nagase S. Pathogenic mechanisms of invasive group A streptococcus infections by influenza virus-group A streptococcus superinfection. Microbiol Immunol 2018;62:141-9.   DOI
3 Kracoff SL. Compartment syndrome secondary to group A streptococcus infection in the presence of a congenital hemangioma. Pediatr Emerg Care 2019;35:290-2.
4 Yagupsky P, Giladi Y. Group A beta-hemolytic streptococcal septicemia complicating infected hemangioma in children. Pediatr Dermatol 1987;4:24-6.   DOI
5 Christie CD, Havens PL, Shapiro ED. Bacteremia with group A streptococci in childhood. Am J Dis Child 1988;142:559-61.
6 Stevens DL. Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis 1995;21:977-80.   DOI
7 Factor SH, Levine OS, Harrison LH, Farley MM, McGeer A, Skoff TH, et al. Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis 2005;11:1062-6.   DOI
8 Lamagni TL, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A, Henriques-Normark B, et al. Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 2008;46:2359-67.   DOI
9 Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005;5:685-94.   DOI
10 Nelson GE, Pondo T, Toews KA, Farley MM, Lindegren ML, Lynfield R, et al. Epidemiology of invasive group A streptococcal infections in the United States, 2005-2012. Clin Infect Dis 2016;63:478-86.   DOI
11 Darenberg J, Henriques-Normark B, Lepp T, Tegmark-Wisell K, Tegnell A, Widgren K. Increased incidence of invasive group A streptococcal infections in Sweden, January 2012-February 2013. Euro Surveill 2013;18:20443.
12 Oliver J, Wilmot M, Strachan J, St George S, Lane CR, Ballard SA, et al. Recent trends in invasive group A streptococcus disease in Victoria. Commun Dis Intell (2018) 2019;43.
13 Whitehead BD, Smith HV, Nourse C. Invasive group A streptococcal disease in children in Queensland. Epidemiol Infect 2011;139:623-8.   DOI
14 Yang N, Lee HS, Choi JH, Cho EY, Choi EH, Lee HJ, et al. Clinical manifestations of invasive infections due to Streptococcus pyogenes in children. Korean J Pediatr Infect Dis 2014;21:129-38.   DOI
15 Meehan M, Murchan S, Gavin PJ, Drew RJ, Cunney R. Epidemiology of an upsurge of invasive group A streptococcal infections in Ireland, 2012-2015. J Infect 2018;77:183-90.   DOI
16 Watts V, Balasegaram S, Brown CS, Mathew S, Mearkle R, Ready D, et al. Increased risk for invasive group A streptococcus disease for household contacts of scarlet fever cases, England, 2011-2016. Emerg Infect Dis 2019;25:529-37.   DOI
17 Gherardi G, Vitali LA, Creti R. Prevalent emm types among invasive GAS in Europe and North America since year 2000. Front Public Health 2018;6:59.   DOI
18 Barnett TC, Bowen AC, Carapetis JR. The fall and rise of group A streptococcus diseases. Epidemiol Infect 2018;147:1-6.
19 Cole JN, Barnett TC, Nizet V, Walker MJ. Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol 2011;9:724-36.   DOI
20 Gonzalez-Abad MJ, Alonso Sanz M. Invasive Streptococcus pyogenes infections (2011-2018): emm-type and clinical presentation. An Pediatr (Barc) 2020;92:351-8.   DOI
21 Choi JH, Yang NR, Lee WJ, Lee H, Choi EH, Lee HJ. Distribution of emm types among group A streptococcus isolates from children in Korea. Diagn Microbiol Infect Dis 2015;82:26-31.   DOI
22 Rhie K, Choi EH, Cho EY, Lee J, Kang JH, Kim DS, et al. Etiology of invasive bacterial infections in immunocompetent children in Korea (2006-2010): a retrospective multicenter study. J Korean Med Sci 2018;33:e45.   DOI